We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Gives Tentative Approval to Generic Gleevec
FDA Gives Tentative Approval to Generic Gleevec
November 24, 2009
The FDA has given tentative approval to Sun Pharmaceutical Industries to make a generic version of Novartis’ Gleevec to treat chronic myeloid leukemia.